IGC Pharma: Ascendiant Capital Maintains Buy Rating, Raises PT to $5.

lunes, 23 de febrero de 2026, 5:08 am ET1 min de lectura
IGC--

IGC Pharma: Ascendiant Capital Maintains Buy Rating, Raises PT to $5.

IGC Pharma: Ascendiant Capital Maintains Buy Rating, Raises PT to $5.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios